.jpg)
.png)
Article By:
Clinical Lipidologist, Private Practice
Marlboro, NJ
Diplomate, American Board of Clinical Lipidology
Cardiovascular disease is the leading killer of women,1 accounting for more than 200,000 deaths in the U.S. each year.2 Cardiovascular disease is not simply a disease of older women. Heart attacks afflict one in 90 women ages 45 to 54 years old, exceeding the one in 240 diagnosed with breast cancer.3,4 Despite these sobering statistics, the burden of cardiovascular disease in women remains vastly underappreciated.
Article By:
Division of Cardiocascular Medicine
Perelman School of Medicine, University of Pennsylvania
Philadelphia, PA
Division of Cardiovascular Medicine
Perelman School of Medicine, University of Pennsylvania
Philadelphia, PA
Diplomate, American Board of Clinical Lipidology
The metabolic syndrome is a clustering of interrelated risk factors for cardiovascular (CV) disease and type 2 diabetes.
Article By:
Director of Preventive Cardiology, Pennsylvania Hospital
Clinical Professor of Medicine
Perelman School of Medicine, University of Pennsylvania
Philadelphia, PA
Diplomate, American Board of Clinical Lipidology
Pennsylvania Hospital
Philadelphia, PA
Pennsylvania Hospital
Philadelphia, PA
It is with great pleasure that I update all with the wonderful progress being made by the career development committee. The committee chair, Binh An P. Phan, MD, FNLA, and members come from all regions of the country and from all disciplines. The vitality of our organization is enhanced because of these efforts.
Article By:
Clinical Epidemiology & Biostatistics and Clinical Lipid Professor
Oklahoma University Health Sciences Center
Oklahoma City, OK
Diplomate, American Board of Clinical Lipidology
I am greatly honored and humbled to hold the office of President of the Northeast Lipid Association (NELA). I appreciate the endorsement of this multidisciplinary organization, one in which a nurse practitioner has the opportunity to rise to the level of president. I have been a board member since the inception of this NLA chapter and have had the opportunity to see it grow not only in number but also in professionalism.
Article By:
Secretary, National Lipid Association
Past President, Preventive Cardiovascular Nurses Association
Consultative Education Specialist, Cardiovascular Risk Intervention
University of Pennsylvania Health System-Retired
Philadelphia, PA
Diplomate, Accreditation Council for Clinical Lipidology
After a successful 2014, the National Lipid Association is poised for an even better 2015. We are consistently seeking ways to improve our educational programs and professional development opportunities. We want to continue to be the voice for Clinical Lipidology.
Article By:
Professor of Medicine, Emory University
Atlanta, GA
Director, Lipid Clinic and Cardiovascular Risk Reduction Program
Diplomate, American Board of Clinical Lipidology
In 2014, the Foundation of the National Lipid Association (FNLA), Preventive Cardiovascular Nurses Association (PCNA), and Mended Hearts launched Cholesterol Counts, a program designed to accumulate Internet-based information on how much people know about their cholesterol, how much they care about their cholesterol and whether they are treated if their cholesterol is elevated. The goal of the survey is to get a pulse of cholesterol knowledge in the U.S. and find where gaps may exist.
During February—which is American Heart Month—the National Lipid Association (NLA) would like to recognize the important work underway by Million Hearts. This national initiative was launched by the Department of Health and Human Services in 2012, with the exciting goal of preventing 1 million heart attacks and strokes by 2017.
I hope everyone had a wonderful Holiday Season and a Happy New Year! To kick off the New Year, the Foundation of the National Lipid Association (FNLA) is hard at work with new projects and partnerships.
Article By:
Diplomate, American Board of Clinical Lipidology